CHENGDU Pharmaceutical Co., Ltd. is a high-tech enterprise specializing in pharmaceutical innovation and high-quality drug R&D, production and sales. It has achieved the coverage of the whole ecological pharmaceutical industry chain from intermediates, APIs to preparations.
YJ Pharmaceutical Group Nanjing XX Pharmaceutical Co., Ltd. was invested and built in 2001 by the national key enterprise YJ Pharmaceutical Group. They bearing in mind the corporate mission of "seeking and making progress and protecting all living beings", the company has continuously developed and innovated, and has developed into a national high-tech enterprise integrating scientific research, production and marketing.
Shanghai XX Biotechnology Co., Ltd. is a wholly-owned subsidiary of YR Pharmaceutical Group established in Shanghai in 2015. The R&D base is located in Zhangjiang Medicine Valley, focusing on the research and development of biological drugs.
The XX Genome Center was established by the Food and Health Bureau in May 2020 as a private company limited by guarantee and wholly owned by the local Government. XX Genome Center carries the mission of implementing the “City Genome Project", and is committed to promoting the development of genomic medicine in local City, so that patients can benefit from more accurate diagnosis and more personalized treatment, and strengthen disease prevention and control.